Preparation of poly (butylcyanoacrylate) drug carriers by nanoprecipitation using a pre-synthesized polymer and different colloidal stabilizers

GG Yordanov, CD Dushkin - Colloid and Polymer Science, 2010 - Springer
Classically, drug-loaded poly (alkylcyanoacrylate) colloidal carriers are prepared by the
drug entrapment during emulsion polymerization. However, a number of chemically …

Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles

CE Soma, C Dubernet, D Bentolila, S Benita… - Biomaterials, 2000 - Elsevier
Individual and combined polyalkylcyanoacrylate nanoparticle formulation of cyclosporin A
and doxorubicin were prepared and evaluated in an attempt to show improved growth …

[HTML][HTML] Fabrication of Paclitaxel and 17AAG-loaded Poly-ε-Caprolactone Nanoparticles for Breast Cancer Treatment

YA Berko, AF Funmilola, EO Akala - Journal of pharmaceutics & …, 2021 - ncbi.nlm.nih.gov
Objective: The aim of this study is to design, fabricate and determine the cytotoxic effects of
dual loaded paclitaxel and 17-AAG in stealth polymeric nanoparticles. The nanoparticles …

Biodegradable polymeric nanoparticles as drug carrier for antitumor agents

P Couvreur, L Grislain, V Lenaerts… - Polymeric …, 2018 - taylorfrancis.com
Entrapment of cytotoxic drugs inside endocytizable carriers such as liposomes improves the
specificity of the drug and reduces its toxicity towards non diseased cells. Work in this field …

Entrapment of bioactive molecules in poly (alkylcyanoacrylate) nanoparticles

K Krauel, T Pitaksuteepong, NM Davies… - American Journal of Drug …, 2004 - Springer
Abstract Poly (alkylcyanoacrylate)[PACA] nanoparticles have been studied since the early
1980s as possible colloidal drug delivery systems. Several excellent general reviews have …

Design aspects of poly (alkylcyanoacrylate) nanoparticles for drug delivery

C Vauthier, D Labarre, G Ponchel - Journal of drug targeting, 2007 - Taylor & Francis
Poly (alkylcyanoacrylate)(PACA) nanoparticles were first developed 25 years ago taking
advantage of the in vivo degradation potential of the polymer and of its good acceptance by …

The effect of hydrophilic chain length and iRGD on drug delivery from poly (ε-caprolactone)-poly (N-vinylpyrrolidone) nanoparticles

Z Zhu, C Xie, Q Liu, X Zhen, X Zheng, W Wu, R Li… - Biomaterials, 2011 - Elsevier
Poly (ε-caprolactone)-b-Poly (N-vinylpyrrolidone)(PCL-b-PVP) copolymers with different
PVP block length were synthesized by xanthate-mediated reverse addition fragment transfer …

Conclusion and future prospective of polymeric nanoparticles for cancer therapy

R Shukla, M Handa, SB Lokesh, M Ruwali… - … nanoparticles as a …, 2019 - Elsevier
Cancer is a broad term that incorporates various types of tumors that can affect any part of
the body. Effective treatment of cancer must include targeted chemotherapeutic agents to the …

Radiation sterilisation of doxorubicin bound to poly (butyl cyanoacrylate) nanoparticles

O Maksimenko, E Pavlov, E Toushov, A Molin… - International journal of …, 2008 - Elsevier
Doxorubicin-loaded poly (butyl cyanoacrylate)(PBCA) nanoparticles were prepared by
anionic polymerisation under non-aseptic conditions. The feasibility of sterilisation of this …

Polybutylcyanoacrylate nanoparticles and drugs of the platinum family: Last status

DRA Fatemeh, H Ebrahimi Shahmabadi… - Indian Journal of Clinical …, 2014 - Springer
Cisplatinum and carboplatinum drugs from platinum-containing family are anti-cancer drugs.
Using these drugs causes side effects. Targeted and selective prescription decreases side …